Targeted Biospecimens BIO-OPTIONS offers prospectively designed specimen collection protocols and a large in-house library of FFPE tissue blocks, frozen tissue, and blood with associated clinical data, presenting a strong opportunity to upsell standardized, high-quality biospecimens for sponsor-led studies and biomarker validation projects.

Retrospective Testing The ability to test banked specimens retrospectively for newly discovered biomarkers expands the usable pool of samples for ongoing or upcoming studies, enabling faster study timelines and potential multi-biomarker panels for pharmaceutical and diagnostic collaborations.

Clinical Network A nationwide network of US community hospitals and clinics positions BIO-OPTIONS to offer broad access to diverse patient populations, which can be leveraged to support multi-site trials, rare biomarker cohorts, and real-world evidence programs.

Physician Owned Being physician owned and operated may enhance clinical credibility and trust with major biopharma and diagnostics customers, facilitating high-touch engagement, study design collaboration, and long-term supplier partnerships.

Proven Track Record Ongoing programs with numerous pharma and diagnostics companies and frequent citations in major biotech publications and patents indicate a credible value proposition for strategic collaborations, including preferred supplier status and co-development opportunities.